Sign up to save your podcasts
Or
Share Moderna’s Rise, JCP’s Split
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Moderna’s Rise, JCP’s Split
Moderna shares pop 20% on encouraging test results. JC Penney’s plan to survive involves splitting into two separate public companies: one for retail, one as a REIT. Bill Barker analyzes those stories as we dip into the Fool Mailbag to discuss retail and diversification.
View all episodes
By The Motley Fool
4.7
16041,604 ratings
Moderna shares pop 20% on encouraging test results. JC Penney’s plan to survive involves splitting into two separate public companies: one for retail, one as a REIT. Bill Barker analyzes those stories as we dip into the Fool Mailbag to discuss retail and diversification.
More shows like MarketFoolery
View all
Motley Fool Money
3,229 Listeners
InvestTalk
1,497 Listeners
Motley Fool Answers
807 Listeners
Rule Breaker Investing
949 Listeners
Investing Insights
534 Listeners
Bloomberg Surveillance
1,178 Listeners
Masters in Business
2,189 Listeners
Industry Focus
825 Listeners
The Investing for Beginners Podcast - Your Path to Financial Freedom
1,422 Listeners
Wall Street Breakfast
1,037 Listeners
The Best One Yet
9,714 Listeners
Chit Chat Stocks
195 Listeners
Ready For Retirement
835 Listeners
The Canadian Investor
85 Listeners
Early Retirement - Financial Freedom (Investing, Tax Planning, Retirement Strategy, Personal Finance)
591 Listeners
The Morgan Housel Podcast
997 Listeners
Stock Market Today With IBD
52 Listeners